Miyazawa M, Nishio J, Chesebro B
National Institute of Allergy and Infectious Diseases, Rocky Mountain Laboratories, Hamilton, Montana 59840.
J Exp Med. 1988 Nov 1;168(5):1587-605. doi: 10.1084/jem.168.5.1587.
T cells primed specifically for the envelope glycoprotein of Friend murine leukemia helper virus (F-MuLV) were prepared by immunizing mice with a recombinant vaccinia virus that expressed the entire env gene of F-MuLV. Significant proliferative responses of F-MuLV envelope-specific, H-2a/b T cells were observed when the T cells were stimulated with antigen-pulsed peritoneal exudate cells (PEC) having the b allele at the K, A beta, A alpha, and E beta loci of the H-2. On the other hand, PEC having only the kappa allele at these loci did not induce the envelope-specific T cell proliferation, even when the PEC had the b allele at the E alpha, S, or D loci. F-MuLV envelope-specific proliferation of H-2a/b T cells under the stimulation of antigen-pulsed, H-2a/b PEC was specifically blocked with anti-I-Ab and anti-I-Ek mAbs but not with anti-Kb, anti-Kk, or anti-I-Ak mAbs. Moreover, (B10.MBR x A/WySn)F1 mice that have the b allele only at the K locus but not in I-A subregion were nonresponders to the envelope glycoprotein, and the bm12 mutation at the A beta locus completely abolished the T cell responsiveness to this antigen. These results indicate that proliferative T cells recognize a limited number of epitopes on F-MuLV envelope protein in the context of I-Ab, hybrid I-Ak/b, and/or hybrid I-Ek/b class II MHC molecules but fail to recognize the same envelope protein in the context of I-Ak or I-Ek molecules. This influence of the H-2I region on T cell recognition of the envelope glycoprotein appeared to control in vivo induction of protective immunity against Friend virus complex after immunization with the vaccinia-F-MuLV env vaccine. Thus, these results provide, for the first time, direct evidence for Ir gene-controlled responder/nonresponder phenotypes influencing the immune response to a pathogenic virus of mice.
通过用表达弗氏小鼠白血病辅助病毒(F-MuLV)完整env基因的重组痘苗病毒免疫小鼠,制备了对F-MuLV包膜糖蛋白具有特异性的T细胞。当用在H-2的K、Aβ、Aα和Eβ位点具有b等位基因的抗原脉冲腹膜渗出细胞(PEC)刺激这些T细胞时,观察到F-MuLV包膜特异性、H-2a/b T细胞有显著的增殖反应。另一方面,即使这些位点仅具有κ等位基因的PEC在Eα、S或D位点具有b等位基因,也不会诱导包膜特异性T细胞增殖。在抗原脉冲的H-2a/b PEC刺激下,H-2a/b T细胞的F-MuLV包膜特异性增殖被抗I-Ab和抗I-Ek单克隆抗体特异性阻断,但不被抗Kb、抗Kk或抗I-Ak单克隆抗体阻断。此外,仅在K位点而非I-A亚区具有b等位基因的(B10.MBR×A/WySn)F1小鼠对包膜糖蛋白无反应,Aβ位点的bm12突变完全消除了T细胞对该抗原的反应性。这些结果表明,增殖性T细胞在I-Ab、杂交I-Ak/b和/或杂交I-Ek/b II类MHC分子的背景下识别F-MuLV包膜蛋白上有限数量的表位,但在I-Ak或I-Ek分子的背景下无法识别相同的包膜蛋白。H-2I区域对T细胞识别包膜糖蛋白的这种影响似乎控制了用痘苗-F-MuLV env疫苗免疫后对弗氏病毒复合物的体内保护性免疫诱导。因此,这些结果首次为Ir基因控制的反应者/无反应者表型影响小鼠对致病病毒的免疫反应提供了直接证据。